Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» BioCryst's immune disorder drug succeeds in mid-stage trial
BioCryst's immune disorder drug succeeds in mid-stage trial
BioCryst's immune disorder drug succeeds in mid-stage trial
Submitted by
admin
on May 27, 2014 - 9:24am
Source:
Yahoo/Reuters
News Tags:
Biocryst
BCX4161
hereditary angiodema
Headline:
BioCryst's immune disorder drug succeeds in mid-stage trial
Do Not Allow Advertisers to Use My Personal information
